Phillip Frost

Angel Investor · Phillip Frost

Phillip Frost is an angel investor who primarily targets the **biotechnology and healthcare sectors**, focusing on companies developing pharmaceuticals, diagnostics, and medical devices [1][2][6]. His notable portfolio includes **Eloxx Pharmaceuticals**, **Protalix BioTherapeutics** (where he invested 1 million), **Cocrystal Pharma**, **ChromaDex**, and **MusclePharm** [2][7][9]. Frost is often…

Focus: Dr. Phillip Frost serves as an Advisor at MBF Healthcare Partners. He presently serves as Chairman of the Board and Chief Executive Officer of OPKO Health, Inc. (NYSE: OPK), a specialty pharmaceutical company. He is Chairman of the Board of Directors of TEVA Pharmaceuticals, Ltd. (NASDAQ: TEVA), Ladenburg Thalmann Financial Services, Inc. (AMEX: LTS), and Prolor Biotech, Inc. (AMEX: PBTH) while also serving as a Director of Castle Brands, Inc. (AMEX: ROX). Previously, he served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation (AMEX: IVX) until its sale to TEVA for $8.5 billion, and Director of Continucare Corp. (NYSE: CNU) prior to its sale to Metropolitan Health Networks Inc. (AMEX: MDF). He also served as Chairman on the Board of Directors of IVAX Diagnostic (AMEX: IVD), and as Co-Vice Chairman of the American Stock Exchange (NYSE: NYX) and Northrop Grumman (NYSE: NOC). He serves on the Board of Regents of the Smithsonian Institution, is a member
Location: Miami Beach, FL, United States

Website

Browse all investors · Browse founders